GeneTex
  • Country / Location Selection

United States (US)

ARHI blocking peptide

Cat. No. GTX17241-PEP

Application

Neutralizing/Inhibition
Package
50 μg ($139)
PRODUCT

Summary

ARHI peptide is used for blocking the activity of ARHI antibody (catalog number GTX17241).

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Diras Family Gtpase 3 , Arhi , Noey2 , Diras3

Background

This gene is a member of the ras superfamily, and is expressed in normal ovarian and breast epithelial cells, but not in ovarian and breast cancers. It is an imprinted gene, with monoallelic expression of the paternal allele, which is associated with growth suppression. Thus, this gene appears to be a putative tumor suppressor gene whose function is abrogated in ovarian and breast cancers. [provided by RefSeq, Oct 2010]

Research Area

REFERENCE

There are currently no references for ARHI blocking peptide (GTX17241-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for ARHI blocking peptide (GTX17241-PEP). Be the first to share your experience with this product.
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139